Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Procter & Gamble

This article was originally published in The Rose Sheet

Executive Summary

Company confirms its sales and earnings guidance for the second quarter of fiscal year 2007, projecting sales growth of 5%-8% and organic sales growth of 4%-7%. The company will announce final results for the quarter Jan. 30, 2007. Q1 revenue increased 11% to $5.6 bil. due to growth across all categories, P&G said during Dec. 14 analyst call. Organic sales volume in the skin care division was up double digits, driven by the launch of Olay Definity and the performance of OlayRegenerist (1"The Rose Sheet" Nov. 6, 2006, p. 8)...

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts